Asahi shares mark weekly slide after cyberattack halts production
STUART, Fla. - Health In Tech (NASDAQ:HIT), an Insurtech platform company with a market capitalization of $158.45 million, announced key leadership changes aimed at strengthening its artificial intelligence capabilities and expanding revenue growth. According to InvestingPro data, the company has demonstrated strong financial health with a 29.68% revenue growth in the last twelve months.
The company appointed Dustin Plantholt as Chief Artificial Intelligence & Marketing Officer, promoting him from his previous role as Chief Growth Officer. Plantholt, who was named Entrepreneur’s Metaverse Advisor of the Year in 2022, will lead the company’s AI strategy and marketing initiatives.
Additionally, Zain Hasan has joined Health In Tech as Head of Revenue and Growth. Hasan brings 15 years of experience in the benefits and insurance sector and previously helped build Quantas Advisors into a national employee benefits agency.
"Artificial intelligence is at the core of our future," said Tim Johnson, CEO of Health In Tech, in a press release statement. "Dustin’s appointment underscores how central AI is to our strategy."
The leadership changes come as Health In Tech prepares to launch its next-generation AI Engine, designed to provide real-time insights and automate decision-making for brokers, TPAs, and carrier partners.
Plantholt assumed his new role effective September 1, 2025. He has extensive experience in AI architecture and has led initiatives integrating artificial intelligence into broker-facing technologies.
Hasan, a serial entrepreneur and five-time Founding CEO, has received industry recognitions including Cigna Gold Circle and has been featured as an Inc. 5000 Honoree.
Health In Tech operates as an Insurtech platform company that aims to improve healthcare industry processes through vertical integration, simplification, and automation. The company’s strong fundamentals are reflected in its impressive gross profit margin of 70.96% and positive earnings expectations for the current fiscal year. For more detailed financial analysis and exclusive insights, investors can access additional ProTips and metrics through InvestingPro.
In other recent news, Health In Tech Inc. reported its second-quarter earnings for 2025, revealing an earnings per share (EPS) of $0.01, which was below the forecasted $0.02, representing a 50% negative surprise. However, the company saw a significant increase in revenue, reaching $9.3 million, an 86% rise compared to the previous year. Additionally, Health In Tech announced a new collaboration with Verdegard Administrators to integrate its Enhanced Do It Yourself Benefit Systems platform with Verdegard’s services for self-funded health insurance plans. The company also regained compliance with Nasdaq’s minimum bid price requirement, having satisfied the rule that mandates a minimum closing bid price of $1.00 per share. Furthermore, Health In Tech’s Compensation Committee approved restricted stock awards for its executive team in connection with the development of two new company programs. CEO Tim Johnson was granted a total of 34,000 shares, CFO Linlin (Julia) Qian received 27,000 shares, and CTO Mo Imran Yousuf was awarded 7,000 shares. These developments highlight the company’s recent activities and strategic initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.